• Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
ICRG - International Center for Responsible Gaming
  • About Us
    • Our Mission
    • Our Team
    • Our Funding
  • Our Research
    • Our Process
    • Funded Research
    • Resources
    • Apply for ICRG Funding
    • Brief Biosocial Gambling Screen
    • Gambling and Health Series
  • What You Can Do
    • Industry Professionals
    • Tribal Nations
    • Regulators & Policymakers
    • Treatment Providers
    • The Wider Public
  • Insights
    • Thought Leadership
    • Tribal Engagment
    • Events Recap
    • Research Highlights
    • Press Releases
    • Blog
  • Events
    • Upcoming Events
    • Events Calendar
    • Webinars
    • Past Webinars
  • Connect With Us
    • Contact Us
    • Get Help
    • Donate
  • Donate
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Blog - Latest News
Research Milestones Research Milestones

Estimating the Prevalence of Disordered Gambling Behavior in The United States and Canada: A Meta-Analysis

In 1996, the ICRG awarded its first grant to Harvard Medical School’s Division on Addictions, led by Howard Shaffer, Ph.D., to conduct a meta-analysis of prevalence studies in order to determine a rate of how many people in the U.S. have a gambling problem. The research team examined 120 prevalence studies to gather data for their analysis.

‍
The study’s findings indicated that approximately 1.14 percent to 1.60 percent of the adult population could be classified as experiencing pathological problems associated with gambling. These estimates were considered the most accurate at the time and were praised by the National Research Council of the National Academy of Sciences in
their publication Pathological Gambling: A Critical Review (1999) for providing the best current estimates of gambling-related issues in the general adult U.S. population and
selected subpopulations.
‍

The initial study was published in the American Journal of Public Health in 1999, and an updated version was released in 2001 in the Canadian Journal of Public Health.

‍

Year:
Type: Research Milestones
November 27, 2022/by icrg_admin
Share this entry
  • Share on Facebook
  • Share on X
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
Search Search

Recent Posts

  • From Bingo Halls To Major Economic Engines: The Evolution Of Tribal Gaming
  • Sports Betting Trends And How Tribes Are Shaping The Future Of The Industry
  • CAN PROBLEM GAMBLING COEXIST WITH OTHER MENTAL HEALTH ISSUES?
  • UNDERSTANDING RISK FACTORS ACROSS SPORTS BETTING AND CASINO GAMBLING
  • NEXT.IO AND TRENDS FROM ICRG PRESIDENT MICHAEL SOLL

Categories

  • Blog
  • Centers of Excellence
  • Conference
  • Events Recap
  • Gambling Addiction
  • Industry
  • Media
  • News Release
  • Position Available
  • Press Release
  • Project Grants
  • Public Health
  • Research Highlights
  • Research Milestones
  • Resources
  • Scientific Achievement Award
  • Thought Leadership
  • Tribal Engagment
  • Uncategorized

Events

  • Upcoming Events
  • Events Calendar
  • Webinars
  • Past Webinars
ICRG logo

About Us

  • Our Mission
  • Our Team
  • Our Funding

Our Research

  • Our Process
  • Funded Research
  • Resources
  • Apply for Funding
  • Brief Biosocial Gambling Screen
  • Gambling and Health Series

What You Can Do

  • Industry Professionals
  • Tribal Nations
  • Regulators & Policymakers
  • Treatment Providers
  • The Wider Public

Insights

  • Thought Leadership
  • Tribal Engagment
  • Events Recap
  • Research Highlights
  • Press Releases
  • Blog

Connect With Us

  • Contact Us
  • Get Help
  • Events
  • Donate
© Copyright - ICRG - International Center for Responsible Gaming
  • Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
Link to: Double-Blind Study of Naltrexone and Placebo in The Treatment of Pathological Gambling Disorder Link to: Double-Blind Study of Naltrexone and Placebo in The Treatment of Pathological Gambling Disorder Double-Blind Study of Naltrexone and Placebo in The Treatment of Pathological...
Scroll to top Scroll to top Scroll to top